CAPDM Submission to the PMPRB December 2022 Revised Guidelines Consultation

Submitted on behalf of the members of the Canadian Association for Pharmacy Distribution Management (CAPDM), CAPDM’s response to the PMPRB’s 2022 Consultation reflected that CAPDM members support medicine affordability, but not at the cost of accessibility. CAPDM urged the PMPRB to suspend the current consultation process, to undertake comprehensive consultation with all supply chain stakeholders, and to conduct impact assessments of the Draft Guidelines to inform and protect affordability and accessibility of medications for all Canadians.

CAPDM Submission to the PMPRB December 2022 Revised Guidelines Consultation